In vivo prostate cancer detection and grading using restriction spectrum imaging-MRI.
about
Restriction spectrum imaging: An evolving imaging biomarker in prostate MRI.Voxel Level Radiologic-Pathologic Validation of Restriction Spectrum Imaging Cellularity Index with Gleason Grade in Prostate CancerRestriction Spectrum Imaging Improves Risk Stratification in Patients with Glioblastoma.Imaging of local recurrence in prostate cancer.
P2860
In vivo prostate cancer detection and grading using restriction spectrum imaging-MRI.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 January 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vivo prostate cancer detection and grading using restriction spectrum imaging-MRI.
@en
In vivo prostate cancer detection and grading using restriction spectrum imaging-MRI.
@nl
type
label
In vivo prostate cancer detection and grading using restriction spectrum imaging-MRI.
@en
In vivo prostate cancer detection and grading using restriction spectrum imaging-MRI.
@nl
prefLabel
In vivo prostate cancer detection and grading using restriction spectrum imaging-MRI.
@en
In vivo prostate cancer detection and grading using restriction spectrum imaging-MRI.
@nl
P2093
P2860
P50
P356
P1476
In vivo prostate cancer detection and grading using restriction spectrum imaging-MRI.
@en
P2093
D J A Margolis
J K Parsons
J M Kuperman
K C McCammack
N M Schenker-Ahmed
P2860
P2888
P304
P356
10.1038/PCAN.2015.61
P577
2016-01-12T00:00:00Z
P6179
1015255786